reference bmd (Laboratory Specialists Inc)
Structured Review

Reference Bmd, supplied by Laboratory Specialists Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+bmd/reference+bmd/pmc11837567-78-17-0
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution"
Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution
Journal: Journal of Clinical Microbiology
doi: 10.1128/jcm.00926-24
Figure Legend Snippet: Example picture of A. baumannii read by reference BMD and ComASP (red circle indicates MIC) (a) Reference BMD: Cefiderocol MIC = 64 µg/mL, (b) ComASP: Cefiderocol MIC = 128 µg/ml (MIC by CLSI read = 8 µg/mL).
Techniques Used:
Figure Legend Snippet: Summary of ComASP using 2 different reading methods compared to CLSI BMD MIC by bacterial species for combined clinical and challenge organisms (category agreement and errors based on FDA breakpoints)
Techniques Used: Inhibition
Figure Legend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 210 Enterobacterales* (combined clinical and challenge isolates; ComASP reading method; FDA/CLSI Breakpoints [indicated with red-dotted lines]).
Techniques Used: Comparison
Figure Legend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 126 P . aeruginosa (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).
Techniques Used: Comparison
Figure Legend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 92 A . baumannii (combined clinical and challenge isolates; ComASP reading method) (a) FDA Breakpoints (indicated with red lines). (b) CLSI Breakpoints (indicated with red-dotted lines).
Techniques Used: Comparison
Figure Legend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for 40 S . maltophilia (combined clinical and challenge isolates; ComASP reading method; CLSI breakpoint [indicated with red-dotted line]).
Techniques Used: Comparison
Figure Legend Snippet: Comparison of ComASP MIC distribution to BMD MIC distribution for Enterobacterales species that are not FDA clinically indicated (combined clinical and challenge isolates) (a) Consolidated Enterobacterales (non-clinically indicated species)*, CLSI Read, EA = 76.7% (b) Consolidated Enterobacterales (non-clinically indicated species)*, ComASP Read, EA = 95.3%.
Techniques Used: Comparison
Related Articles
Inhibition:Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Article Snippet: The performance of the Liofilchem Compact Antimicrobial Susceptibility Panel (ComASP) Cefiderocol was evaluated in a multicenter study.. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa clinical isolates and challenge isolates were tested by three and one sites, respectively.. Minimum inhibitory concentra tion (MIC) testing was performed by the Clinical and Laboratory Standards Institute (CLSI) broth microdilution and ComASP, which included two reading endpoints (CLSI read; MIC is the first well in which reduction of growth is <1 mm or light haze/faint turbidity] and ComASP [ComASP read; MIC is the first well at which 100% inhibition of growth occurs]). Comparison:Article Title: A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Article Snippet: The performance of the Liofilchem Compact Antimicrobial Susceptibility Panel (ComASP) Cefiderocol was evaluated in a multicenter study.. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa clinical isolates and challenge isolates were tested by three and one sites, respectively.. Minimum inhibitory concentra tion (MIC) testing was performed by the Clinical and Laboratory Standards Institute (CLSI) broth microdilution and ComASP, which included two reading endpoints (CLSI read; MIC is the first well in which reduction of growth is <1 mm or light haze/faint turbidity] and ComASP [ComASP read; MIC is the first well at which 100% inhibition of growth occurs]). |
